Merus N.V. - Common Shares (NQ:MRUS)

96.22 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist

Price and Volume

Volume	1
Open	96.22
Bid (Size)	95.80 (400)
Ask (Size)	96.50 (300)
Prev. Close	96.22
Today's Range	96.22 - 96.22
52wk Range	33.19 - 96.28
Shares Outstanding	46,530,884
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC Encourages CADE, THS, CMA, MRUS Shareholders to Contact the Firm to Discuss Their Rights

December 03, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗

December 03, 2025

One investor is making a bold bet on Amylyx just as its 2026 catalyst calendar starts to take shape.

Via The Motley Fool

Performance

YTD	+127.5%	+127.5%
1 Month	+1.2%	+1.2%
3 Month	+45.3%	+45.3%
6 Month	+71.8%	+71.8%
1 Year	+111.5%	+111.5%

More News

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗

December 03, 2025

Via The Motley Fool

Merus Stock Soars To All-Time High As Genmab Announces $8B Takeover — Analysts Turn Cautious, Retail Crowd Cheers The Deal ↗

September 30, 2025

Via Stocktwits

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗

December 03, 2025

Via The Motley Fool

Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights

November 22, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety

October 24, 2025

From Merus N.V.

Via GlobeNewswire

HALPER SADEH LLC ENCOURAGES MTSR, HOLX, MRUS SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

October 23, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS

October 23, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 14, 2025

From Merus N.V.

Via GlobeNewswire

Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 13, 2025

From Merus N.V.

Via GlobeNewswire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates PINC, ODP, PRO, MRUS on Behalf of Shareholders

October 09, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholders

October 07, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq - EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq - BRY), Semler Scientific, Inc. (Nasdaq – SMLR)

October 07, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRO, EA, MRUS on Behalf of Shareholders

October 04, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Unusual volume stocks are being observed in Thursday's session. ↗

October 02, 2025

Via Chartmill

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders

October 01, 2025

From Halper Sadeh LLC

Via GlobeNewswire

MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS

September 30, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

This Maplebear Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

September 30, 2025

Via Benzinga

Wall Street Lights Up as Cannabis Stocks Blaze Higher, Biotech Melts Down ↗

September 30, 2025

Via Chartmill

Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes

September 29, 2025

Via MarketMinute

Let's take a look at the stocks that are in motion in today's session. ↗

September 29, 2025

Via Chartmill

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholders

September 29, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Crude Oil Falls Sharply; Carnival Posts Upbeat Earnings ↗

September 29, 2025

Via Benzinga

Frequently Asked Questions

Is Merus N.V. - Common Shares publicly traded?

Yes, Merus N.V. - Common Shares is publicly traded.

What exchange does Merus N.V. - Common Shares trade on?

Merus N.V. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Merus N.V. - Common Shares?

The ticker symbol for Merus N.V. - Common Shares is MRUS on the Nasdaq Stock Market

What is the current price of Merus N.V. - Common Shares?

The current price of Merus N.V. - Common Shares is 96.22

When was Merus N.V. - Common Shares last traded?

The last trade of Merus N.V. - Common Shares was at 12/04/25 04:00 PM ET

What is the market capitalization of Merus N.V. - Common Shares?

The market capitalization of Merus N.V. - Common Shares is 4.48B

How many shares of Merus N.V. - Common Shares are outstanding?

Merus N.V. - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.